Life Sciences

AI-enhanced formulation partnership announced

Quotient Sciences and Acesion Pharma partnered to use active machine learning and Bayesian optimization for AI-enhanced drug formulation.

Quotient Sciences and Acesion Pharma announced a collaboration applying AI-enhanced formulation development within Quotient’s Translational Pharmaceutics platform. The solution uses active machine learning and Bayesian optimization to identify and prioritize drug products considered most likely to succeed in clinical development. The approach is intended to improve formulation decisions by iteratively learning from available data and focusing experiments on promising candidates. The partnership links computational optimization with translational pharmaceutical development. The available article does not disclose the specific compounds, datasets, expected development milestones, or clinical outcomes.

Original source: PharmaTimes

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI